Orange Book product · Brand (NDA)

AURYXIA

FERRIC CITRATE

Brand (NDA)NDA 205874TE ABRX KERYX BIOPHARMS

Sep 05, 2014

Approved

Brand (NDA)

Application

TE code

Listed patents

Approval
FDA approval date of this drug product.
Sep 05, 2014
12 yr ago
Patent 8093423 expires
Listed method-of-use patent (U-1577) expiration.
Apr 21, 2026
2 mo ago
Today
Patent 10300039 expires
Listed method-of-use patent (U-2549) expiration.
Jul 21, 2030
in 4 yr 2 mo
Patent 9387191 expires
Listed drug product patent expiration.
Jul 21, 2030
in 4 yr 2 mo

Active ingredient

FERRIC CITRATE

Strength

EQ 210MG IRON

Dosage form

TABLET

Route

ORAL

TE code

Application

NDA 205874

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
8093423	Apr 21, 2026	2 mo ago	U-1577
10300039	Jul 21, 2030	in 4 yr 2 mo	U-2549
9387191	Jul 21, 2030	in 4 yr 2 mo	Product